Distinct complication profiles: a comparative study of Ethiopian and non-Ethiopian adults with type 1 diabetes
Alena Kirzhner1, Amir Bashkin2, Hefziba Green1
1Department of Internal Medicine A, Kaplan Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Rehovot, Israel.
Aims:
Ethiopian ethnicity is linked to a higher risk of diabetes, yet data on disease characteristics and complications in Ethiopians with type 1 diabetes (T1D) are limited. This study aimed to assess clinical features and complication rates in Ethiopian versus non-Ethiopian T1D patients.
Methods:
This population-based retrospective cohort study included all patients insured in Clalit Health Services (CHS) who were considered to have T1D according to study criteria between January 1, 2000, and December 31, 2022. Patients were followed until December 31, 2023, for the development of composites of microvascular and macrovascular complications.
Results:
Among 12,759 T1D patients, 672 (5.3%) were Ethiopian, and 4,375 (34%) were diagnosed before age 18. The mean age was 30.4 years, 54% were male, and the mean BMI was 25.4 kg/m². Average follow-up was 10.9 years. In multivariable Cox regression models, Ethiopian ethnicity was an independent risk factor for microvascular complications (hazard ratio [HR] 1.325; 95% CI 1.124-1.563; p = 0.001) but was associated with a lower risk of macrovascular complications (HR 0.606; 95% CI 0.425-0.863; p < 0.001).
Conclusions:
The striking differences in diabetes-associated complications underscore the need for ethnic-specific and population-specific follow-up, therapeutic, and preventive approaches for T1D patients.
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...


